Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Docetaxel GP-Pharm 20mg


Contraindicated
Embryotoxic and foetotoxic in rabbits and rats

Contraindicated
Docetaxel GP-Pharm 20mg :
Type Medicine Authorised
Originator Taxotere 20mg
Agent Mediterranean Pharmaceutical Company
Distributor Mediterranean Pharmaceutical Company
Laboratory GP-Pharm
Responsible Party GP-Pharm, SA
Origin Spain
Manufacturer GP-Pharm SA
Manufacturing Type G
Origin Argentina
ATC L01CD02

Your comment will appear shortly after approval

Docetaxel GP-Pharm 20mg :

Revision Date : 13/04/2015


Effect Frequency
Abdominal pain Very Common
Abdominal pain upper Common
Acute leukaemia Not known
Acute myeloid leukaemia Not known
Acute respiratory distress syndrome Not known
Alopecia Very Common
ALT increased Common
Amenorrhoea (amenorrhea) Very Common
Anaemia Very Common
Anaphylactic shock Not known
Arrhythmia Common
Arthralgia (Pain joint) (Joint ache) Very Common
Ascites Not known
AST increased Common
Asthenia Very Common
Back pain Very Common
Blood alkaline phosphatase increased Common
Blood bilirubin increased Common
Bone marrow failure Not known
Bone pain Very Common
Bronchospasm Not known
Burning sensation Not known
Cancer pain Common
Cardiac failure Common
Chest discomfort Not known
Chest pain Very Common
Chills Very Common
Colitis Not known
Colitis ischaemic Not known
Congestive cardiomyopathy Not known
Congestive heart failure Common
Conjunctivitis Very Common
Constipation Very Common
Cough Very Common
Cutaneous lupus erythematosus Not known
Cystoid macular oedema Not known
Dacryostenosis acquired Not known
Deafness Not known
Decreased appetite Very Common
Dehydration Common
Dermatitis Common
Dermatitis bullous Not known
Diarrhoea (Diarrhea) Very Common
Disseminated intravascular coagulation Not known
Dizziness Common
Dry mouth (Xerostomia) Common
Dry skin Common
Dysaesthesia Not known
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Very Common
Dyspepsia Very Common
Dysphagia Very Common
Dyspnoea (dyspnea) Very Common
Embolism venous Not known
Epistaxis (Nasal bleeding) Very Common
Erythema Very Common
Erythema multiforme Not known
Exfoliative rash Common
Fatigue Very Common
Febrile neutropenia (Neutropenic fever) Very Common
Fluid retention Very Common
Flushing Not known
Gastroduodenal haemorrhage Common
Gastrointestinal pain Common
Gastrointestinal perforation Not known
Haemorrhage Common
Hand and foot syndrome (Palmar-plantar erythrodysaesthesia syndrome) Very Common
Headache Very Common
Hepatitis Not known
Hot flush Very Common
Hypersensitivity Very Common
Hypertension Common
Hypoacusis Very Common
Hypoesthesia Very Common
Hyponatraemia (Hyponatremia) Not known
Hypotension Common
Ileus Not known
Infection Very Common
Influenza-like illness Very Common
Infusion site discolouration Not known
Infusion site erythema Not known
Infusion site extravasation Not known
Infusion site inflammation Not known
Infusion site phlebitis Not known
Infusion site reactions Common
Infusion site swelling Not known
Injection site dryness Not known
Insomnia Very Common
Interstitial pneumonitis Not known
Intestinal obstruction Not known
Lacrimation increased (Epiphora) Very Common
Laryngeal pain Very Common
Left ventricular dysfunction Common
Lethargy Very Common
Loss of consciousness Not known
Lyell Syndrome (Toxic epidermal necrolysis) Not known
Lymphoedema Very Common
Mucosal inflammation Very Common
Myalgia Very Common
Myelodysplastic syndrome Not known
Myocardial infarction Not known
Myocardial ischaemia Common
Nail discolouration Common
Nail disorders Very Common
Nasopharyngitis Very Common
Nausea Very Common
Neuropathy peripheral Common
Neurotoxicity Uncommon
Neutropenia Very Common
Neutropenic colitis Not known
Neutropenic infection Very Common
Neutropenic sepsis Very Common
Non-cardiac chest pain Common
Odynophagia Very Common
Oedema Very Common
Oedema peripheral Very Common
Oesophagitis Very Common
Onychalgia Not known
Onycholysis Common
Oral candidiasis Common
Ototoxicity Not known
Pain Very Common
Pain in extremity (Pain in limb) Very Common
Paraesthesia (paresthesia) Very Common
Parosmia Very Common
Pericardial effusion Not known
Peripheral motor neuropathy Very Common
Peripheral sensory neuropathy Very Common
Pharyngitis Very Common
Phlebitis Common
Photopsia Not known
Pleural effusion Not known
Pneumonia Very Common
Pneumonitis Not known
Pulmonary fibrosis Not known
Pulmonary oedema Not known
Pyrexia Very Common
Radiation pneumonitis Not known
Rash erythematous Common
Rash generalised Not known
Rash pruritic Very Common
Recall phenomenon Not known
Renal failure Not known
Respiratory failure Not known
Rhinorrhoea Very Common
Scleroderma-like reaction Not known
Seizures Not known
Sepsis (Systemic infection) (Sepsis state) Very Common
Skin disorders Very Common
Skin exfoliation (Flaking skin) Common
Skin rash Very Common
Skin reaction Very Common
Skin toxicity Very Common
Somnolence Uncommon
Stevens-Johnson syndrome Not known
Stomatitis Very Common
Syncope Uncommon
Thrombocytopenia (Thrombopenia) Very Common
Vein disorder Common
Visual disturbance Not known
Visual field defect Not known
Vomiting Very Common
Weight decreased (Weight loss) Very Common
Weight increased (weight gain) Very Common

Different Units By MoH Code

Docetaxel GP-Pharm 20mg  MoH 3576 :
Form Concentrate for solution for infusion
Packaging Bottle
Package Size 1+1
Strength 20mg/0.5ml
Public Price 4593238,65 L.L.
Stratum B
NSSF ✘
Quarantine ✘
Reg. Number 194595/04
Submission date 01/01/2004
Registration Year 2004
Archived Date 2015


NB : Change of trade name Texot to Adenex in 2014

Price Comparison

● Country: Lebanon
● Form: Concentrate for solution for infusion
● Package Size: 1+1
● Public Price: 4593238.65 LBP ( 4,593,238.65 LBP )
● Pack size unit used: 1
● Cost/Unit: 4593238,65 LBP ( 4,593,238.00 LBP )
● Pricing Date: 10/01/2024

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Breast cancer : (Adults)
● Cost/Unit: 4593238,65 LBP ( 4,593,238.00 LBP )
● Cost/Day: 18372954,6 LBP ( 18,372,954.00 LBP )
● Cost/Month: 22966193,25 LBP ( 22,966,193.00 LBP )
Gastric adenocarcinoma : (Adults)
● Cost/Unit: 4593238,65 LBP ( 4,593,238.00 LBP )
● Cost/Day: 18372954,6 LBP ( 18,372,954.00 LBP )
● Cost/Month: 22966193,25 LBP ( 22,966,193.00 LBP )
Head and neck carcinoma : (Adults)
● Cost/Unit: 4593238,65 LBP ( 4,593,238.00 LBP )
● Cost/Day: 18372954,6 LBP ( 18,372,954.00 LBP )
● Cost/Month: 22966193,25 LBP ( 22,966,193.00 LBP )
Non-small cell lung cancer : (Adults)
● Cost/Unit: 4593238,65 LBP ( 4,593,238.00 LBP )
● Cost/Day: 18372954,6 LBP ( 18,372,954.00 LBP )
● Cost/Month: 22966193,25 LBP ( 22,966,193.00 LBP )
Prostate cancer : (Adults)
● Cost/Unit: 4593238,65 LBP ( 4,593,238.00 LBP )
● Cost/Day: 18372954,6 LBP ( 18,372,954.00 LBP )
● Cost/Month: 22966193,25 LBP ( 22,966,193.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info